ConductScience.org, home

Paper30701409

Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.

Ghiaccio V and 3 others. Mol Diagn Ther, 2019. Cited by 20 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges. Papers, record 30701409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30701409

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges.
PubMed
Journal
Mol Diagn Ther
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.7
iCite
Revised in PubMed
2020-03-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ghiaccio VValentina
2Chappell MMaxwell
3Rivella SStefano
4Breda LLaura

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic TherapyMajor topic
HemoglobinopathiesMajor topic
beta-GlobinsMajor topic
Epigenesis, Genetic
Gene Editing
Humans
Treatment Outcome

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 DK090554NIDDK NIH HHSUnited StatesR01DK090554PubMed and NIHNIH RePORTER
R01 DK095112NIDDK NIH HHSUnited StatesR01DK095112PubMed and NIHNIH RePORTER

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121,881,051Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.Blood2011https://conductscience.org/library/papers/21881051PubMed
226,551,060Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.Nat Biotechnol2015https://conductscience.org/library/papers/26551060PubMed
327,820,943CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells.Nature2016https://conductscience.org/library/papers/27820943PubMed
421,321,359Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.Blood2011https://conductscience.org/library/papers/21321359PubMed
519,997,089Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells.Mol Ther2010https://conductscience.org/library/papers/19997089PubMed
618,650,378In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18650378PubMed
720,676,099Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin.Nat Genet2010https://conductscience.org/library/papers/20676099PubMed
86,183,5865-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.N Engl J Med1982https://conductscience.org/library/papers/6183586PubMed
912,391,330Permanent and panerythroid correction of murine beta thalassemia by multiple lentiviral integration in hematopoietic stem cells.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12391330PubMed
106,200,161Is there a threshold level of fetal hemoglobin that ameliorates morbidity in sickle cell anemia?Blood1984https://conductscience.org/library/papers/6200161PubMed
1128,956,530Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6.Elife2017https://conductscience.org/library/papers/28956530PubMed
1219,056,937Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.Science2008https://conductscience.org/library/papers/19056937PubMed
1312,050,007Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes.Biophys Chem2002https://conductscience.org/library/papers/12050007PubMed
1424,597,865Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.N Engl J Med2014https://conductscience.org/library/papers/24597865PubMed
1523,939,622CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity.Nucleic Acids Res2013https://conductscience.org/library/papers/23939622PubMed
1628,330,619Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy.Stem Cell Reports2017https://conductscience.org/library/papers/28330619PubMed
179,734,950Granulocytosis causing sickle-cell crisis.Lancet1998https://conductscience.org/library/papers/9734950PubMed
1830,282,642Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients.Blood Adv2018https://conductscience.org/library/papers/30282642PubMed
1928,895,851Gene Therapy Approaches to Hemoglobinopathies.Hematol Oncol Clin North Am2017https://conductscience.org/library/papers/28895851PubMed
2029,892,062p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.Nat Med2018https://conductscience.org/library/papers/29892062PubMed

See all 102 references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
37,497,271The APC-EPCR-PAR1 axis in sickle cell disease.Front Med (Lausanne)2023https://conductscience.org/library/papers/37497271PubMed
37,298,481Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.Int J Mol Sci2023https://conductscience.org/library/papers/37298481PubMed
35,526,095Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies.Mol Ther2022https://conductscience.org/library/papers/35526095PubMed
34,766,559Molecular genetics of β-thalassemia: A narrative review.Medicine (Baltimore)2021https://conductscience.org/library/papers/34766559PubMed
34,522,846The EHA Research Roadmap: Anemias.Hemasphere2021https://conductscience.org/library/papers/34522846PubMed
34,284,828PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients' RBCs ex vivo in the frame of Protein Replacement Therapy.J Biol Res (Thessalon)2021https://conductscience.org/library/papers/34284828PubMed
33,525,591Genome Editing for β-Hemoglobinopathies: Advances and Challenges.J Clin Med2021https://conductscience.org/library/papers/33525591PubMed
32,439,7262'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalance.Haematologica2019https://conductscience.org/library/papers/32439726PubMed
32,406,490Genome editing strategies for fetal hemoglobin induction in beta-hemoglobinopathies.Hum Mol Genet2020https://conductscience.org/library/papers/32406490PubMed
32,167,945Small molecule therapeutics to treat the β-globinopathies.Curr Opin Hematol2020https://conductscience.org/library/papers/32167945PubMed
31,705,806Adenovirus vectors in hematopoietic stem cell genome editing.FEBS Lett2019https://conductscience.org/library/papers/31705806PubMed
31,700,592Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches.Mediterr J Hematol Infect Dis2019https://conductscience.org/library/papers/31700592PubMed
30,945,167Disruptive Technology: CRISPR/Cas-Based Tools and Approaches.Mol Diagn Ther2019https://conductscience.org/library/papers/30945167PubMed
30,945,166Rare Opportunities: CRISPR/Cas-Based Therapy Development for Rare Genetic Diseases.Mol Diagn Ther2019https://conductscience.org/library/papers/30945166PubMed
30,903,542Theranostics of Genetic Diseases.Mol Diagn Ther2019https://conductscience.org/library/papers/30903542PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
HBB3,043PubTator's text mininghttps://conductscience.org/library/genes/3043

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30701409

GET https://conductscience.org/api/papers/v1/30701409/references?page=2